Cargando…
Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
The endocannabinoid system (ECS) is composed of the two canonical receptor subtypes; type-1 cannabinoid (CB1R) and type 2 receptor (CB2R), endocannabinoids (eCBs) and enzymes responsible for the synthesis and degradation of eCBs. Recently, with the identification of additional lipid mediators, enzym...
Autores principales: | Ishiguro, Hiroki, Kibret, Berhanu Geresu, Horiuchi, Yasue, Onaivi, Emmanuel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237241/ https://www.ncbi.nlm.nih.gov/pubmed/35774086 http://dx.doi.org/10.3389/fpsyt.2022.828895 |
Ejemplares similares
-
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
por: Kibret, Berhanu Geresu, et al.
Publicado: (2022) -
Cannabinoid CB2 Receptor Gene and Environmental Interaction in the Development of Psychiatric Disorders
por: Ishiguro, Hiroki, et al.
Publicado: (2018) -
Editorial: Unravelling the role of CB2r in neuropsychiatric diseases
por: Onaivi, Emmanuel S.
Publicado: (2023) -
Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation
por: Kibret, Berhanu Geresu, et al.
Publicado: (2023) -
Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder
por: Canseco-Alba, Ana, et al.
Publicado: (2022)